- Report
- August 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 194 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 181 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 198 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 194 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 199 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 181 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 185 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- September 2025
- 284 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 283 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- April 2025
- 302 Pages
Global
From €3925EUR$4,450USD£3,397GBP
- Training
- November 2025
- 2 Days
Europe
€1553EUR$1,823USD£1,299GBP
€1792EUR$2,103USD£1,499GBP
- Report
- January 2025
- 82 Pages
Brazil
From €3087EUR$3,500USD£2,672GBP
- Report
- April 2024
- 182 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- February 2024
- 114 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- May 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP
- Report
- May 2025
- 69 Pages
Canada
From €4189EUR$4,750USD£3,626GBP
- Report
- February 2024
- 122 Pages
North America
From €3043EUR$3,450USD£2,634GBP

The Veterinary Biologics market is a segment of the Animal Healthcare/Veterinary industry that focuses on the production and distribution of biological products used to diagnose, prevent, and treat diseases in animals. These products include vaccines, antisera, diagnostic kits, and other biological products. Veterinary biologics are regulated by the United States Department of Agriculture (USDA) and are subject to stringent safety and efficacy standards.
The Veterinary Biologics market is a rapidly growing segment of the Animal Healthcare/Veterinary industry, driven by the increasing demand for animal health products and the growing awareness of animal health and welfare. Veterinary biologics are used to protect animals from a variety of diseases, including rabies, distemper, and parvovirus.
Some of the major companies in the Veterinary Biologics market include Merck Animal Health, Boehringer Ingelheim Animal Health, Zoetis, Elanco Animal Health, and Ceva Animal Health. Show Less Read more